Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RSMDF) Revenue (2016 - 2025)

Historic Revenue for Resmed (RSMDF) over the last 17 years, with Q4 2025 value amounting to $1.4 billion.

  • Resmed's Revenue rose 1097.58% to $1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.4 billion, marking a year-over-year increase of 956.7%. This contributed to the annual value of $5.1 billion for FY2025, which is 983.99% up from last year.
  • According to the latest figures from Q4 2025, Resmed's Revenue is $1.4 billion, which was up 1097.58% from $1.3 billion recorded in Q3 2025.
  • In the past 5 years, Resmed's Revenue ranged from a high of $1.4 billion in Q4 2025 and a low of $768.8 million during Q1 2021
  • In the last 5 years, Resmed's Revenue had a median value of $1.1 billion in 2023 and averaged $1.1 billion.
  • As far as peak fluctuations go, Resmed's Revenue dropped by 8.94% in 2021, and later surged by 2919.58% in 2023.
  • Resmed's Revenue (Quarter) stood at $894.9 million in 2021, then rose by 15.52% to $1.0 billion in 2022, then grew by 12.48% to $1.2 billion in 2023, then increased by 10.26% to $1.3 billion in 2024, then rose by 10.98% to $1.4 billion in 2025.
  • Its Revenue stands at $1.4 billion for Q4 2025, versus $1.3 billion for Q3 2025 and $1.3 billion for Q2 2025.